In addition, chronic constipation may occur in patients suffering ... multiple sclerosis. Idiopathic Paraneoplastic syndromes, Parkinson's disease, dementia, scleroderma, post-viral colon-paresis ...

IBS-C and chronic idiopathic constipation (also known as functional constipation) share many of the same symptoms. According ...

Medscape Medical News, October 26, 2018 FDA Panel Backs Prucalopride for Chronic Idiopathic Constipation An FDA panel unanimously recommended prucalopride oral tablets for the treatment of adults ...

Motegrity is a medication used to treat chronic idiopathic constipation (CIC) in adults. The FDA has granted Competitive Generic Therapy (CGT) designation to the company's Prucalopride ...

Bethesda, MD) for the treatment of chronic, idiopathic constipation in adults. In 2008, the FDA approved lubiprostone (Amitiza ®) for the treatment of constipation-predominant IBS in women ≥18 ...

Prucalopride, a serotonin-4 receptor agonist, is indicated for the treatment of chronic idiopathic constipation in adults. The first generic version of Motegrity ® has been approved by the Food and ...

ANI is offering prucalopride tablets, which is the generic of Takeda's Motegrity. Motegrity is used in adults to treat chronic idiopathic constipation. "We are delighted to build momentum early in ...

including irritable bowel syndrome with constipation (IBS-C) and CIC (chronic idiopathic constipation). Both drugs are ...